COAG
Hemab Therapeutics Holdings, Inc.
32.60$
-1.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Hemab Therapeutics Holdings, Inc. (COAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -13 | -15 | -22 | -23 | |
| 0.1 | 0.1 | 0.1 | -0.1 | |
| 0.5 | 0.5 | 1.3 | 2.0 | |
| 1.4 | -2.4 | 0.4 | -0.4 | |
| 0.0 | 0.0 | 0.1 | 0.1 | |
| – | – | -16 | -107 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | -0.5 | 318 | |
| -19 | 6.1 | -38 | 188 | |
| -13 | -15 | -22 | -23 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.